MedPath

A clinical trial study to determine the role of chemical thrombo-prophylaxis in patients undergoing arthroscopic anterior cruciate ligament reconstructive surgery

Not Applicable
Conditions
Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
Registration Number
CTRI/2021/06/034419
Lead Sponsor
Dinshaw Pardiwala
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1Patients undergoing arthroscopic ACL reconstruction (with or without associated meniscus or chondral surgery)

2.Age group 16 to 60 year

3Gender Male and female patients will be included

4Patients who would voluntarily agree to sign informed consent form

5.Patients who would be available to perform the postoperative color Doppler evalua-tion at KDAH.

Exclusion Criteria

1Patients undergoing arthroscopic ACL reconstruction associated with other ligament re-constructive surgery that is arthroscopic bicruciate reconstructions and multiple ligament reconstructions

2Age group : <16 years & >60 years

3Patients diagnosed with acute or chronic DVT on preoperative venous color Doppler

4Patients having a high risk of DVT which would under normal circumstances warrant mandatory chemical thromboprophylaxis including previous history of DVT or PE, his-tory of recent malignancy (within the past 12 months), pregnancy, or patients on oral contraceptives.

5History of thrombophilic conditions

6A patient having more than 3 risk factors for developing DVT would be excluded. These include : smoking, nicotine abuse, hormonal replacement therapy, antipsychotic treatment, varicose vein, family history of thrombosis, ongoing treatment with steroids, anticoagulant or antiplatelet agents, history of gastrointestinal bleeding in the past 2 weeks

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath